{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T07:14:09Z","timestamp":1725434049295},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,5,15]]},"DOI":"10.2169\/internalmedicine.5992-20","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T22:09:16Z","timestamp":1608588556000},"page":"1561-1565","source":"Crossref","is-referenced-by-count":2,"title":["Fabry Disease on Peritoneal Dialysis with Cardiac Involvement"],"prefix":"10.2169","volume":"60","author":[{"given":"Sayako","family":"Koga-Kobori","sequence":"first","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sawa","sequence":"additional","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"},{"name":"Okinaka Memorial Institute, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Kido","sequence":"additional","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinari","family":"Sekine","sequence":"additional","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Yamanouchi","sequence":"additional","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Hayami","sequence":"additional","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Suwabe","sequence":"additional","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Kinowaki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital, Japan"},{"name":"Department of Pathology, Yokohama City University Hospital Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Okinaka Memorial Institute, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"},{"name":"Okinaka Memorial Institute, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bishop DF, Kornreich R, Desnick RJ. Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3' untranslated region. Proc Natl Acad Sci U S A 85: 3903-3907, 1988.","DOI":"10.1073\/pnas.85.11.3903"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mehta A, Ricci R, Widmer U, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34: 236-242, 2004.","DOI":"10.1111\/j.1365-2362.2004.01309.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Branton MH, Schiffmann R, Sabnis SG, et al. Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore) 81: 122-138, 2002.","DOI":"10.1097\/00005792-200203000-00003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nakao S, Kodama C, Takenaka T, et al. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype. Kidney Int 64: 801-807, 2003.","DOI":"10.1046\/j.1523-1755.2003.00160.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Fujii H, Kono K, Goto S, et al. Prevalence and cardiovascular features of Japanese hemodialysis patients with Fabry disease. Am J Nephrol 30: 527-535, 2009.","DOI":"10.1159\/000250968"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Linthorst GE, Bouwman MG, Wijburg FA, Aerts JM, Poorthuis BJ, Hollak CE. Screening for Fabry disease in high-risk populations: a systematic review. J Med Genet 47: 217-222, 2010.","DOI":"10.1136\/jmg.2009.072116"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kubo T. Fabry disease and its cardiac involvement. J Gen Fam Med 18: 225-229, 2017.","DOI":"10.1002\/jgf2.76"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Koch M, Haastert B, Kohnle M, et al. Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronic kidney disease. Eur J Heart Failure 14: 530-539, 2012.","DOI":"10.1093\/eurjhf\/hfs035"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sanchez JE, Ortega T, Rodriguez C, et al. Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure. Nephrol Dial Transplant 25: 605-610, 2010.","DOI":"10.1093\/ndt\/gfp484"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Barbey F, Brakch N, Linhart A, et al. Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arterioscler Thromb Vasc Biol 26: 839-844, 2006.","DOI":"10.1161\/01.ATV.0000209649.60409.38"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Desnick RJ, Brady R, Barranger J, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138: 338-346, 2003.","DOI":"10.7326\/0003-4819-138-4-200302180-00014"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Takenaka T, Teraguchi H, Yoshida A, et al. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study. J Cardiol 51: 50-59, 2008.","DOI":"10.1016\/j.jjcc.2007.12.001"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Rombach SM, Dekker N, Bouwman MG, et al. Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease. Biochim Biophys Acta 1802: 741-748, 2010.","DOI":"10.1016\/j.bbadis.2010.05.003"},{"key":"14","unstructured":"14. Marieke B, Reynir A, Carla E, et al. Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document. Orphanet J Rare Dis 10-36, 2015."},{"key":"15","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1161\/CIRCULATIONAHA.108.841494","volume":"119","author":"BL Thurberg","year":"2009","unstructured":"15. Thurberg BL, Fallon JT, Mitchell R, et al. Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy. Circulation 119: 2561-2567, 2009.","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gubler MC, Lenoir G, Grunfeld JP, et al. Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int 13: 223-235, 1978.","DOI":"10.1038\/ki.1978.32"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/10\/60_5992-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T04:03:43Z","timestamp":1621051423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/10\/60_5992-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,15]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5992-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,15]]}}}